Nina Bhardwaj

Nina Bhardwaj

Auto-generated profile, based on publicly available information

Nina Bhardwaj

Division of Hematology and Oncology, Hess Center for Science & Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2021 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
MSMansi Saxena
Mansi Saxena
SBSjoerd H. van der Burg
Sjoerd H. van der Burg
CMCornelis J. M. Melief
Cornelis J. M. Melief
NBNina Bhardwaj
Nina Bhardwaj

27 December 2016 in Cell Research
Verified
Journal Article
Closed access
RSRachel L Sabado
Rachel L Sabado
SBSreekumar Balan
Sreekumar Balan
NBNina Bhardwaj
Nina Bhardwaj

1 May 2014 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
ISInês Pires da Silva
Inês Pires da Silva
AGAnne Gallois
Anne Gallois
SJSonia Jimenez-Baranda
Sonia Jimenez-Baranda
SKShaukat Khan
Shaukat Khan
AAAna C. Anderson
Ana C. Anderson
NBNina Bhardwaj
Nina Bhardwaj
The immunoregulatory protein T-cell immunoglobulin- and mucin-domain–containing molecule-3 (Tim-3) mediates T-cell exhaustion and contributes to the suppression of immune responses in both viral infections and tumors. Tim-3 blockade reverses the exhausted phenotype of CD4+ and CD8+ T cells in several chronic diseases, including melanoma. Interestingly, natural killer (NK) cells constitutively express Tim-3; however, the role of Tim-3 in modulating the function of these innate effector cells remains unclear, particularly in human diseases. In this study, we compared the function of Tim-3 in NK cells from healthy donors and patients with metastatic melanoma. NK cells from the latter were functionally impaired/exhausted, and Tim-3 blockade reversed this exhausted phenotype. Moreover, Tim-3 expression levels were correlated with the stage of the disease and poor prognostic factors. These data indicate that Tim-3 can function as an NK-cell exhaustion marker in advanced melanoma and support the development of Tim-3–targeted therapies to restore antitumor immunity. Cancer Immunol Res; 2(5); 410–22. ©2014 AACR.

1 February 2018 in Trends in Cancer
Verified
Journal Article
Closed access
MSMansi Saxena
Mansi Saxena
NBNina Bhardwaj
Nina Bhardwaj

20 April 2023 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MPMatthew D. Park
Matthew D. Park
IRIvan Reyes-Torres
Ivan Reyes-Torres
JLJessica LeBerichel
Jessica LeBerichel
PHPauline Hamon
Pauline Hamon
NLNelson M. LaMarche
Nelson M. LaMarche
MMMiriam Merad
Miriam Merad

30 November 2020 in Cell
Verified
Journal Article
Closed access
VRVladimir Roudko
Vladimir Roudko
CBCansu Cimen Bozkus
Cansu Cimen Bozkus
TOTheofano Orfanelli
Theofano Orfanelli
CMChristopher B. McClain
Christopher B. McClain
CCCaitlin Carr
Caitlin Carr
NBNina Bhardwaj
Nina Bhardwaj